Taiko Pharmaceutical Co.,Ltd. provided earnings guidance for the year ending December 2024. For the year, the company expects net sales of ¥6,800 million, operating profit of ¥410 million, profit attributable to owners of parent of ¥350 million and basic earnings per share of ¥6.98.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
401 JPY | -4.07% | +11.08% | +32.34% |
1st Jan change | Capi. | |
---|---|---|
+32.34% | 134M | |
+21.28% | 44.4B | |
+24.60% | 23.03B | |
+19.22% | 15.14B | |
+12.87% | 13.12B | |
+44.67% | 11.85B | |
-8.33% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.52B |
- Stock Market
- Equities
- 4574 Stock
- News Taiko Pharmaceutical Co.,Ltd.
- Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2024